Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4203836 | 0.95 | ALDH1A1 (0.48) | NAAAALDH1A1HCAR2EPHX1ATM | |
| SCHEMBL9013100 | 0.85 | NAAA (0.43) | NAAAALDH1A1HCAR2EPHX1ATM | |
| SCHEMBL6161479 | 0.81 | NAAA (0.48) | NAAAALDH1A1HCAR2EPHX1TSHR | |
| SCHEMBL9453048 | 0.81 | NAAA (0.48) | NAAAALDH1A1HCAR2EPHX1TSHR | |
| SCHEMBL9460966 | 0.80 | NAAA (0.41) | NAAAALDH1A1HCAR2EPHX1ATM | |
| SCHEMBL8402246 | 0.78 | NAAA (0.42) | NAAAALDH1A1HCAR2EPHX1ATM | |
| SCHEMBL3761727 | 0.77 | NAAA (0.44) | NAAAALDH1A1HCAR2EPHX1TSHR | |
| SCHEMBL5143996 | 0.77 | ALDH1A1 (0.47) | NAAAALDH1A1HCAR2EPHX1ATM | |
| SCHEMBL9586962 | 0.76 | NAAA (0.43) | NAAAALDH1A1HCAR2EPHX1TSHR | |
| SCHEMBL7042625 | 0.76 | NAAA (0.47) | NAAAALDH1A1HCAR2EPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7102019-B2 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | STREICHER HARALD (DE) | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | PROC, ALDH16A1, RCN1 | NAAA 1364/4885ALDH1A1 14/4885HCAR2 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.